These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19563346)

  • 41. Lamotrigine pharmacokinetics in patients receiving felbamate.
    Gidal BE; Kanner A; Maly M; Rutecki P; Lensmeyer GL
    Epilepsy Res; 1997 Apr; 27(1):1-5. PubMed ID: 9169285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Felbamate: a new antiepileptic drug.
    Wagner ML
    Am J Hosp Pharm; 1994 Jul; 51(13):1657-66. PubMed ID: 7942890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome.
    Siegel H; Kelley K; Stertz B; Reeves-Tyer P; Flamini R; Malow B; Gaillard WD; Ko D; Theodore WH
    Epilepsy Res; 1999 Apr; 34(2-3):91-7. PubMed ID: 10210023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience.
    Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV
    Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Felbamate.
    Med Lett Drugs Ther; 1993 Nov; 35(910):107-9. PubMed ID: 8232064
    [No Abstract]   [Full Text] [Related]  

  • 46. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
    Steinhoff BJ
    Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic drug monitoring of felbamate].
    Tribut O; Bentué-Ferrer D; Verdier MC;
    Therapie; 2010; 65(1):35-8. PubMed ID: 20205993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Felbamate urolithiasis.
    Sparagana SP; Strand WR; Adams RC
    Epilepsia; 2001 May; 42(5):682-5. PubMed ID: 11380578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Qualitative changes of anticonvulsant action of felbamate during development in rats.
    Haugvicová R; Kubová H; Mares P
    Brain Dev; 1998 Jun; 20(4):222-6. PubMed ID: 9661966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro.
    Kapetanovic IM; Torchin CD; Thompson CD; Miller TA; McNeilly PJ; Macdonald TL; Kupferberg HJ; Perhach JL; Sofia RD; Strong JM
    Drug Metab Dispos; 1998 Nov; 26(11):1089-95. PubMed ID: 9806951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroprotective effect of felbamate after kainic acid-induced status epilepticus.
    Chronopoulos A; Stafstrom C; Thurber S; Hyde P; Mikati M; Holmes GL
    Epilepsia; 1993; 34(2):359-66. PubMed ID: 8453945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood-brain barrier penetration of felbamate.
    Cornford EM; Young D; Paxton JW; Sofia RD
    Epilepsia; 1992; 33(5):944-54. PubMed ID: 1396440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A self-complementary, self-assembling microsphere system: application for intravenous delivery of the antiepileptic and neuroprotectant compound felbamate.
    Lian H; Steiner SS; Sofia RD; Woodhead JH; Wolf HH; White HS; Shen GS; Rhodes CA; McCabe RT
    J Pharm Sci; 2000 Jul; 89(7):867-75. PubMed ID: 10861587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of epilepsy with third-line antiepileptic drugs: felbamate, tiagabine, and sulthiame].
    Chahem J; Bauer J
    Nervenarzt; 2007 Dec; 78(12):1407-12. PubMed ID: 17604973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Felbamate overdose: a case report and discussion of a new antiepileptic drug.
    Nagel TR; Schunk JE
    Pediatr Emerg Care; 1995 Dec; 11(6):369-71. PubMed ID: 8751173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Felbamate: a new antiepileptic drug.
    Brodie MJ
    Lancet; 1993 Jun; 341(8858):1445-6. PubMed ID: 8099147
    [No Abstract]   [Full Text] [Related]  

  • 57. Felbamate in epilepsy therapy: evaluating the risks.
    Pellock JM
    Drug Saf; 1999 Sep; 21(3):225-39. PubMed ID: 10487399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of partial seizures and seizure-like activity with felbamate in six dogs.
    Ruehlmann D; Podell M; March P
    J Small Anim Pract; 2001 Aug; 42(8):403-8. PubMed ID: 11518421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Felbamate: consensus of current clinical experience.
    Pellock JM; Faught E; Leppik IE; Shinnar S; Zupanc ML
    Epilepsy Res; 2006 Oct; 71(2-3):89-101. PubMed ID: 16889941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat.
    Germanò A; Caffo M; Angileri FF; Arcadi F; Newcomb-Fernandez J; Caruso G; Meli F; Pineda JA; Lewis SB; Wang KK; Bramanti P; Costa C; Hayes RL
    J Neurotrauma; 2007 Apr; 24(4):732-44. PubMed ID: 17439355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.